Wall Street Loves Broadcom, Oscar Health, and Amazon Stocks Today
Briefly

Wall Street Loves Broadcom, Oscar Health, and Amazon Stocks Today
"It's always a good idea to keep track of analysts' stock upgrades. Often, they're influenced by (1) company fundamentals, such as financial health, future growth, and even meetings with management; (2) industry and market trends, including specific market conditions and economics; (3) earnings and financial data, including earnings reports that came in better than expected, or competitive analysis of a competitor, and (4) guidance. However, before jumping into a stock just because your favorite analyst upgraded it, do your own due diligence, fundamentally and technically."
"says the dip is an opportunity, noting that shares re-traced to pre-earnings levels and are now about 10% off November highs. Just yesterday, Goldman Sachs reiterated its buy rating on Amazon, noting that it's well-positioned for the holidays. Not long ago, analysts at KeyBanc Capital said Amazon should benefit from the AI boom. The analysts say Amazon's AWS is still growing strong. It also believes that the ramp of gigawatt data center clusters and customers like Anthropic are potential drivers of revenue acceleration into 2026."
Analyst stock upgrades often reflect company fundamentals, industry and market trends, earnings results, and forward guidance. Investors should conduct fundamental and technical due diligence before acting on upgrades. JPMorgan reiterated an outperform on Amazon after shares retraced to pre-earnings levels and remain about 10% below November highs; Goldman Sachs also reiterated a buy and KeyBanc raised an overweight view with a $300 target, citing AWS growth, gigawatt data centers, and customers like Anthropic as potential revenue drivers into 2026. Goldman raised Broadcom’s target to $435 anticipating sustained AI strength and large AI revenue growth; Raymond James resumed an outperform with a $420 target.
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]